Wells Fargo & Company Immunocore Holdings PLC Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Wells Fargo & Company holds 83,055 shares of IMCR stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,055
Previous 81,782
1.56%
Holding current value
$2.42 Million
Previous $2.77 Million
6.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMCR
# of Institutions
140Shares Held
40.8MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$206 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$190 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$142 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$72.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$63 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.28B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...